Lincomycin (in the form of lincomycin hydrochloride)
Code ATC: J01FF02
Antibiotics (group of linkosamides)
In therapeutic doses, antibiotic acts as bacteriostatic. At higher concentrations it has a bacterial effect. It inhibits protein synthesis in microbial cell. It is ctive mainly against gram-positive cocci. It is effective against staphylococci, resistant to penicillin, tetracyclines, chloramphenicol, streptomycin, cephalosporins.
Resistance to lincomycin develops slowly.
Bacterial infections, caused by susceptible microorganisms (mainly staphylococci and streptococci, especially by microorganisms, resistant to penicillins, and in allergy to penicillins): acute and chronic osteomyelitis (due to the fact that lincomycin is accumulated in bone tissue, it is one of most effective drug for treatment acute and chronic osteomyelitis and other infections of bones and joints), sepsis, subacute bacterial endocarditis, chronic pneumonia, lung abscess, pleural empyema, pleuritis, otitis, purulent synovitis, postoperative suppurative complications, wound infection, skin and soft tissue infections (pyogenic dermatitis, furunculosis, phlegmon, erysipelas).
30% solution for injection, in ampoules of 1 ml and 2 ml.